永利股份(300230.SZ):擬與羅晨輝、上海縱升共設上海永利愷博傳動系統
格隆匯 3 月 5日丨永利股份(300230.SZ)公佈,公司計劃與自然人羅晨輝、上海縱升企業管理合夥企業(有限合夥)(“上海縱升”)共同出資設立上海永利愷博傳動系統有限公司(暫定名,最終以市場監督管理局核准登記為準,“合資公司”或“永利愷博”)。
合資公司投資總額為人民幣5000萬元,其中,公司以自有貨幣資金出資人民幣3000萬元,佔投資總額的60%;羅晨輝以貨幣資金出資人民幣1250萬元,佔投資總額的25%;上海縱升以貨幣資金出資人民幣750萬元,佔投資總額的15%。合資公司主要從事同步帶及相關配件的生產、加工及銷售活動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.